1h Free Analyst Time
The sexually transmitted disease (STD) testing market is forecasted to grow by USD 32.37 billion during 2023-2028, accelerating at a CAGR of 5.6% during the forecast period. The report on the sexually transmitted disease (STD) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of STDs, presence of favorable reimbursement policies, and increased initiatives by governments worldwide.
The sexually transmitted disease (STD) testing market is segmented as below:
By Product
- Laboratory testing device
- POC testing device
By Disease Type
- Chlamydia
- Gonorrhea
- Syphilis
- Trichomoniasis
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the sexually transmitted disease (STD) testing market covers the following areas:
- Sexually transmitted disease (STD) testing market sizing
- Sexually transmitted disease (STD) testing market forecast
- Sexually transmitted disease (STD) testing market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Disease Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global sexually transmitted disease (STD) testing market: AbbVie Inc., AccuBioTech Co. Ltd., AdvaCare Pharma, BIOGENIX Inc. Pvt. Ltd., CTK Biotech Inc., Everlywell Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline PLC, Goffin Molecular Technologies, Hangzhou Biotest Biotech, Hologic Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., LT Labs, Merck and Co. Inc., Ok Biotech Co Ltd., Priority STD Testing, QIAGEN NV, and RayBiotech Life Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advances in rapid diagnosis of STDs."
According to the report, one of the major drivers for this market is the increasing prevalence of STDs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- AccuBioTech Co. Ltd.
- AdvaCare Pharma
- BIOGENIX Inc. Pvt. Ltd.
- CTK Biotech Inc.
- Everlywell Inc.
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- Goffin Molecular Technologies
- Hangzhou Biotest Biotech
- Hologic Inc.
- Inovio Pharmaceuticals Inc.
- Johnson and Johnson Services Inc.
- LT Labs
- Merck and Co. Inc.
- Ok Biotech Co Ltd.
- Priority STD Testing
- QIAGEN NV
- RayBiotech Life Inc.
